Horizon Pharma PLC (HZNP) Sets New 52-Week Low After Earnings Miss

With 384,400 avg volume, 6 days are for Virtusa Corporation (NASDAQ:VRTU)'s short sellers to cover VRTU's short positions. The SI to Norwood Financial Corporation's float is 0.13%. The average 1 year target price among brokers that have issued a report on the stock in the last year is $21.09. About shares traded. Virtusa Corporation (NASDAQ:VRTU) has declined 13.10% since May 26, 2016 and is downtrending.

Beach Point Capital Management Lp decreased Horizon Pharma Plc (HZNP) stake by 81.63% reported in 2016Q4 SEC filing.

TRADEMARK VIOLATION NOTICE: "Horizon Pharma PLC (HZNP) Sets New 52-Week Low After Earnings Miss" was reported by The Cerbat Gem and is owned by of The Cerbat Gem. The Reaves W H & Company Inc holds 688,858 shares with $28.67 million value, up from 485,858 last quarter. The SI to Horizon Pharma Plc Ord Ireland's float is 8.94%. (NASDAQ:AMD) traded at a yearly high level of $15.55 during the last trading session. The stock of Horizon Pharma PLC (NASDAQ:HZNP) has "Neutral" rating given on Friday, December 9 by Mizuho. It has underperformed by 45.13% the S&P500. Blue Bell Private Wealth Management Llc acquired 60,833 shares as General American Investors (GAM)'s stock rose 1.35%. It also reduced Visa Inc (NYSE:V) stake by 80,363 shares and now owns 2.89M shares. Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) was reduced too.

Investors sentiment increased to 1.83 in Q4 2016. Its down 0.44, from 1.46 in 2016Q3. Horizon Pharma PLC had a positive return on equity of 22.73% and a negative net margin of 1.34%. Consonance Capital Management LP acquired a new stake in shares of Horizon Pharma PLC during the third quarter valued at approximately $67,061,000. The biopharmaceutical company reported $0.21 earnings per share for the quarter, missing analysts' consensus estimates of $0.25 by $0.04.

Historically, if we have a peek at price target revisions, Horizon Pharma PLC (NASDAQ:HZNP)'s price target was revised by the analysts two weeks back on 05/09/17 to set its target price at $19.33 where its twelve month high target price was set at $42 and low at $10 while demonstrating the standard deviation of 11.71. Teacher Retirement Sys Of Texas holds 11,475 shares.

Читайте также: Fresh CCTV images of Manchester bomber released in bid to track movements

Horizon Pharma PLC (NASDAQ:HZNP) last posted its earnings results on Monday, May 8th. Systematic Mgmt Limited Partnership reported 218,495 shares. 240.61 million shares or 0.20% less from 241.09 million shares in 2016Q3 were reported. Deerfield Management Co. increased its stake in shares of Horizon Pharma PLC by 39.2% in the fourth quarter. Sg Americas Lc holds 52,353 shares or 0.02% of its portfolio. Deutsche Bancorporation Ag owns 1,230 shares for 0% of their portfolio. Capital Fund Mgmt holds 291,939 shares or 0.04% of its portfolio.

Moreover, Mirae Asset Glob Invs Com Limited has 0.01% invested in Horizon Pharma PLC (NASDAQ:HZNP). Brandywine Global Inv Management Ltd Co invested in 0.26% or 2.49 million shares. Amer National Co Tx invested 0.14% of its portfolio in Horizon Pharma PLC (NASDAQ:HZNP). 101,900 were accumulated by Parkwood Ltd. Finally, BMO Capital Markets reiterated a "buy" rating and set a $17.00 price target (down from $24.00) on shares of Horizon Pharma PLC in a research note on Tuesday, May 9th. Therefore 56% are positive. Guggenheim assumed coverage on shares of Horizon Pharma PLC in a research note on Monday, February 27th. Three equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. The firm has "Neutral" rating by Citigroup given on Wednesday, January 6. The company was initiated on Monday, June 6 by Goldman Sachs. Mizuho cut Horizon Pharma PLC from a "buy" rating to a "neutral" rating and lowered their price target for the stock from $22.00 to $10.00 in a report on Tuesday, May 9th. As per Tuesday, August 9, the company rating was maintained by Citigroup. Horizon Pharma PLC has a 12-month low of $9.45 and a 12-month high of $23.44. As per Tuesday, November 8, the company rating was maintained by Mizuho.

Since January 1, 0001, it had 1 insider buy, and 4 selling transactions for $1.32 million activity. Mizuho restated a "buy" rating and set a $25.00 price target on shares of Horizon Pharma PLC in a research note on Wednesday, February 22nd.

In other news, Director Michael G. Grey purchased 10,000 shares of the business's stock in a transaction on Wednesday, May 10th. He performs analysis of Companies and publicizes important information for investor/traders community. The stock's market cap is $1.66 billion. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. SunTrust has "Neutral" rating and $40 target. Barclays Capital maintained it with "Equal-Weight" rating and $43 target in Friday, March 18 report. The company was maintained on Monday, October 31 by Mizuho. (NASDAQ:FFIV) on Friday, February 10. The company was maintained on Wednesday, July 29 by Needham. They issued a "buy" rating and a $30.00 price objective for the company.

При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2018 Copyright.
Автоматизированное извлечение информации сайта запрещено.

Код для вставки в блог

Related news